Table 3.
Characteristics of B. pertussis isolates selected for WGS
| Sample ID | Age of children | Vaccine status | Hospitalized | PFGE Clade | PFGE Ref | Year | ptxA | ptxp | prn | Fim2 | Fim3 | Serotyping Fim2/fim3 | # Contigs | GC% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IR44 | 1.5 Month | _ | hospitalized patient | B | (24) | 2012 | PtxA1 | Ptxp1 | Prn1 | Fim2-1 | Fim3 A (3–4) | +/+ | 277 | 67.47% |
| IR92 | 2 Month | _ | hospitalized patient | A (vaccine 134 cluster) | (24) | 2014 | PtxA1 | Ptxp1 | Prn1 | Fim2-1 | Fim3 A (3–4) | +/+ | 299 | 67.46% |
| IR133 | 3 Year | + | hospitalized patient | J (vaccine 134 cluster) | This study | 2015 | PtxA2 | Ptxp1 | Prn1 | _ | Fim3-1 | −/+ | 275 | 67.45% |
| IR37 | 4 Month | + | hospitalized | H (Dominant cluster) | (24) | 2012 | PtxA1 | Ptxp3 | Prn2 | Fim2-1 | Fim3-2 | +/+ | 276 | 67.49% |
| IR175 | 5 Year | + | hospitalized patient | A (Dominant cluster) | This study | 2017 | PtxA1 | Ptxp3 | Prn9 | Fim2-1 | Fim3-2 | +/+ | 285 | 67.76% |
| IR178 | 28 Days | _ | patients died | A (Dominant cluster) | This study | 2018 | PtxA1 | Ptxp3 | Prn2 | Fim2-1 | Fim3-2 | −/+ | 282 | 67.91% |